Abstract
Dyslipidemia and vascular calcification are important predictors of cardiovascular disease (CVD). Vitamin D may have an influence on these two CVD risk markers. We performed a systematic review on vitamin D, dyslipidemia, statins, vascular calcification and CVD. The vast majority of intervention studies did not show an effect of vitamin D on serum cholesterol levels. There is however evidence for a triglyceride-lowering effect of vitamin D which primarily comes from studies with chronic kidney disease patients, a group with elevated triglyceride levels. The previously presumed influence of statins on circulating 25-hydroxyvitamin D levels and on cellular vitamin D actions remains obscure. Experimental studies on vascular calcification and CVD suggest a biphasic effect of vitamin D with harmful effects at both low and high vitamin D levels. Epidemiological studies on vitamin D and vascular calcification are inconsistent at present, but are probably biased by confounding. Prospective cohort studies consistently indicate an enhanced multivariableadjusted CVD mortality risk when circulating 25-hydroxyvitamin D levels are below 25 nmol/l. Adequately designed randomised controlled trials investigating the dose-response effect of vitamin D on different CVD outcome parameters are now warranted.
Keywords: Vitamin D, dyslipidemia, triglycerides, cholesterol, cardiovascular mortality, calcification, dyslipoproteinemia, atheromatous, cytosolic, biphasic, calcitriol, prohormone, osteoporosis, Interleukin, metabolite, supraphysiological, vasculature, hepatocellular, 7-dehydrocholsterol, adolescents
Current Pharmaceutical Design
Title: The Role of Vitamin D in Dyslipidemia and Cardiovascular Disease
Volume: 17 Issue: 9
Author(s): Armin Zittermann, Jan F. Gummert and Jochen Borgermann
Affiliation:
Keywords: Vitamin D, dyslipidemia, triglycerides, cholesterol, cardiovascular mortality, calcification, dyslipoproteinemia, atheromatous, cytosolic, biphasic, calcitriol, prohormone, osteoporosis, Interleukin, metabolite, supraphysiological, vasculature, hepatocellular, 7-dehydrocholsterol, adolescents
Abstract: Dyslipidemia and vascular calcification are important predictors of cardiovascular disease (CVD). Vitamin D may have an influence on these two CVD risk markers. We performed a systematic review on vitamin D, dyslipidemia, statins, vascular calcification and CVD. The vast majority of intervention studies did not show an effect of vitamin D on serum cholesterol levels. There is however evidence for a triglyceride-lowering effect of vitamin D which primarily comes from studies with chronic kidney disease patients, a group with elevated triglyceride levels. The previously presumed influence of statins on circulating 25-hydroxyvitamin D levels and on cellular vitamin D actions remains obscure. Experimental studies on vascular calcification and CVD suggest a biphasic effect of vitamin D with harmful effects at both low and high vitamin D levels. Epidemiological studies on vitamin D and vascular calcification are inconsistent at present, but are probably biased by confounding. Prospective cohort studies consistently indicate an enhanced multivariableadjusted CVD mortality risk when circulating 25-hydroxyvitamin D levels are below 25 nmol/l. Adequately designed randomised controlled trials investigating the dose-response effect of vitamin D on different CVD outcome parameters are now warranted.
Export Options
About this article
Cite this article as:
Zittermann Armin, F. Gummert Jan and Borgermann Jochen, The Role of Vitamin D in Dyslipidemia and Cardiovascular Disease, Current Pharmaceutical Design 2011; 17 (9) . https://dx.doi.org/10.2174/138161211795428786
DOI https://dx.doi.org/10.2174/138161211795428786 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Low Levels of High Density Lipoprotein Increase the Severity of Cerebral White Matter Changes:Implications for Prevention and Treatment of Cerebrovascular Diseases
Current Alzheimer Research Therapeutic Approach on AGE-RAGE Interaction and Its Function in Diabetic Inflammation Process
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Calcium Channel Blockers in the Management of Hypertension in the Elderly
Cardiovascular & Hematological Agents in Medicinal Chemistry Effects of CYP2C19 Polymorphism on Endothelial Function, Arterial Stiffness and Inflammation in Coronary Artery Disease Patients Under Clopidogrel Treatment
Current Pharmaceutical Design Role of Moving Average Analysis for Development of Multi-Target (Q)SAR Models
Mini-Reviews in Medicinal Chemistry Oxidative Stress Drivers and Modulators in Obesity and Cardiovascular Disease: From Biomarkers to Therapeutic Approach
Current Medicinal Chemistry Platelets in Alzheimer’s Disease-Associated Cellular Senescence and Inflammation
Current Pharmaceutical Design Mechanisms of the Beneficial Actions of Ischemic Preconditioning on Subcellular Remodeling in Ischemic-Reperfused Heart
Current Cardiology Reviews Headache: One of the Most Common and Troublesome Adverse Reactions to Drugs
Current Drug Safety Rho Kinase Inhibitors: Potential Treatments for Diabetes and Diabetic Complications
Current Pharmaceutical Design Non-Hormonal Replacement Therapy Regimens: Do they have an Effect on Cardiovascular Risk?
Current Vascular Pharmacology On the Relationship Between the Light/Dark Cycle, Melatonin and Oxidative Stress
Current Pharmaceutical Design Jak2 and Reactive Oxygen Species: A Complex Relationship
Current Chemical Biology Potassium Channel Openers and Improvement of Toxic Stress: Do they have Role in the Management of Inflammatory Bowel Disease?
Inflammation & Allergy - Drug Targets (Discontinued) Nutritional Overview on the Management of Type 2 Diabetes and the Prevention of its Complications
Current Diabetes Reviews Commentary : Hypothesis Focused Ultrasound and NXY-059 in Experimental Cerebral Ischemia: A New Therapeutic Opportunity?
CNS & Neurological Disorders - Drug Targets Current and Future Insights in H. pylori Eradication Regimens: The Need of Tailoring Therapy
Current Pharmaceutical Design New Insights into the Mechanisms Underlying Vascular and Cardiac Effects of Urocortin
Current Vascular Pharmacology Mechanisms Explaining the Influence of Subclinical Hypothyroidism on the Onset and Progression of Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Relationship Between Proinsulin Level and Cardiovascular Risk Factors Clustering: An Epidemiological Study
Vascular Disease Prevention (Discontinued)